BioLine RX Ltd (NASDAQ:BLRX)

2.02
Delayed Data
As of May 22
 +0.17 / +9.19%
Today’s Change
1.20
Today|||52-Week Range
3.28
+24.69%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 9.25, with a high estimate of 10.50 and a low estimate of 8.00. The median estimate represents a +357.92% increase from the last price of 2.02.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in BioLine RX Ltd. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$0.00
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.66%
 
 
 
 
 
 
Growthannually -40.75%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account